Robert A. Blake

6.8k citations
32 papers · 2.4k indexed · 1 hit paper · h-index 16

Impact in

Papers in

    • Protein Degradation and Inhibitors 6
    • PI3K/AKT/mTOR signaling in cancer 6
    • Protein Kinase Regulation and GTPase Signaling 4
    • Ubiquitin and proteasome pathways 4
    • Heat shock proteins research 3
    • Angiogenesis and VEGF in Cancer 3

Robert A. Blake

32 papers receiving 2.3k citations

Hit Papers

SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling 2000 · 520 citations
5200+8+17Years since publication100200300400500

Peers

Robert A. Blake
Comparison fields: 5 of 111
  • Hepatology 323
  • Immunology and Allergy 163
  • Oncology 633
  • Molecular Biology 1.6k
  • Hematology 247
Replace Marina Holgado-Madruga with:
Marina Holgado-Madruga United States
Frauke Bataille Germany
Adrian M. Jubb United Kingdom
Xiaoyan Zhou China
Jiří Ehrmann Czechia
James M. Cleary United States
P. Charles Lin United States
Paola Longati Italy
Radha P. Narsimhan United States
Alexander C. Mackinnon United States
Robert A. Blake relative to Marina Holgado-Madruga United States Marina Holgado-Madruga's profile →
Citations per field
00.5×2.6×
Marina Holgado-Madruga · 1×
Citations per year

Countries citing papers authored by Robert A. Blake

Since Specialization
Citations

This map shows the geographic impact of Robert A. Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Blake more than expected).

Fields of papers citing papers by Robert A. Blake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Blake. The network helps show where Robert A. Blake may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Blake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Blake Line = papers co-authored together Robert A. Blake links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling
Hit paper breakdown →
2000520
2
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.
2003421
3
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
2000402
4 2013256
5 1994115
6
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
200393
7
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.
200392
8
Src promotes PKCdelta degradation.
199986
9 201765
10 200345
11 202045
12 200535
13 200325
14 199424
15 201124
16 201919
17 200614
18 200411
19 202010
20 202410

About Robert A. Blake

Robert A. Blake is a scholar working on Molecular Biology, Oncology, Genetics, Hematology and Organic Chemistry, having authored 32 papers that have together received 2.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Ubiquitin and proteasome pathways (4 papers), Heat shock proteins research (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Advanced Breast Cancer Therapies (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Hepatology (323 citations), Immunology and Allergy (163 citations), Oncology (633 citations), Molecular Biology (1.6k citations) and Hematology (247 citations). Robert A. Blake has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Li Sun, Sara A. Courtneidge, Martin A. Broome, Mikhail L. Gishizky, Xiangdong Liu, Jianming Wu, Julie M. Cherrington, Steve P. Watson, Alexander Laird and Emily Chan. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry, SLAS DISCOVERY, FEBS Letters and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact